Tidutamab (XmAb-18087) is a humanized bispecific antibody targeting the growth inhibitory receptor 2 (SSTR2) and T-cell binding domain (CD3) with antitumor activity for the study of gastric neurosecretory tumors.
Purity:
97.80%
CAS Number:
[2148354-90-7]
Target:
Others|||Integrin
* VAT and and shipping costs not included. Errors and price changes excepted